Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus

Nigar Sekercioglu1, Chrysostomos Dimitriadis, Chrysoula Pipili

  • 1The Home Peritoneal Dialysis Unit, Toronto General Hospital, University Health Network and University of Toronto, 200 Elizabeth Street, 8N-840, Toronto, ON, M5G 2C4, Canada.

Insights

Glycated hemoglobin (HbA1c) levels did not predict survival in diabetic peritoneal dialysis (PD) patients. Neither baseline nor time-averaged HbA1c values showed a significant correlation with patient or PD technique survival.

Area of Science:

  • Nephrology
  • Endocrinology
  • Clinical Research

Background:

  • Glycemic control is crucial for patients with diabetes mellitus.
  • The optimal target for glycated hemoglobin (HbA1c) in peritoneal dialysis (PD) patients with diabetes remains undefined.
  • Understanding glycemic control's impact on PD patient outcomes is essential.

Purpose of the Study:

  • To evaluate the predictive value of predialysis and time-averaged HbA1c on survival in diabetic PD patients.
  • To determine if specific HbA1c targets improve outcomes in this population.

Main Methods:

  • Retrospective study of 91 diabetic PD patients from 2003-2008.
  • Analysis of baseline and time-averaged follow-up HbA1c values.
  • Assessment of correlation with patient and PD technique survival over a median follow-up of 30 months.

Main Results:

  • No statistically significant correlation was found between baseline HbA1c and survival.
  • Time-averaged HbA1c levels (categorized as <6.5%, 6.5-8%, and >8%) did not show significant differences in survival among groups.
  • 40 out of 91 patients died during the follow-up period.

Conclusions:

  • Neither baseline nor time-averaged HbA1c values significantly correlate with patient or PD technique survival.
  • Current HbA1c targets may not be directly predictive of outcomes in diabetic PD patients.
  • Further research may be needed to identify optimal glycemic management strategies for this cohort.
Abstract

Related Concept Videos

Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...